Table 1.
Clinical description of the analyzed population
| Variables | Patients group (n = 25) |
Control group (n = 10) |
P |
|---|---|---|---|
| Male, % | 53.80 | 50.00 | 0.87 |
| Age (y), mean ± SD | 9.95 ± 3.47 | 12.60 ± 3.02 | 0.04 |
| BMI, mean ± SD | 18.16 ± 3.08 | 20.17 ± 2.30 | 0.62 |
| FEV1/FVC pred, mean ± SD | 97.95 ± 8.96 | 98.40 ± 4.65 | 0.88 |
| FEV1% pred, mean ± SD | 100.10 ± 11.75 | 103.30 ± 13.61 | 0.49 |
| FVC% pred, mean ± SD | 93.50 ± 22.02 | 98.60 ± 14.80 | 0.50 |
| FEV1/FVC pred exacerbation, mean ± SD | 87.50 ± 14.90 | – | |
| FEV1% pred exacerbation, mean ± SD | 82.25 ± 19.58 | – | |
| FVC% pred exacerbation, mean ± SD | 88.00 ± 14.85 | – | |
| IgE (IU/mL), mean ± SD | 257.5 ± 326.7 | 7.32 ± 12.66 | 0.02 |
BMI body mass index, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, IgE immunoglobulin E, SD standard deviation